Patents by Inventor Erwin Wagner

Erwin Wagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8105639
    Abstract: A process of precooking grains which comprises the steps of: a) Charging the grains into a reactor in a controlled manner; b) Applying a first negative pressure to the reactor; c) Heating the grains contained in the reactor; d) Applying a second negative pressure to the reactor; and e) Cooling the grains. Equipment for precooking grains comprises at least one reactor, which is associable with means for applying negative pressure.
    Type: Grant
    Filed: July 6, 2009
    Date of Patent: January 31, 2012
    Inventor: Werner Erwin Wagner
  • Patent number: 8023165
    Abstract: Shown is a lens device 16 comprising a displaceable lens 18 and a guide 42, by means of which the lens is guided so as to be capable of being displaced. The lens device 16 comprises a first and a second galvanometric motor 46a, 46b and a first and a second force transmission device 54a, 56a; 54b, 56b, which is coupled to the rotor of the first and second galvanometric motor 46a, 46b, respectively, and which is coupled to the lens 18 at a first and second junction 58a, 58b, respectively. The force transmission device is suitable to convert a rotary motion of the rotor of the first and second galvanometric motor 46a, 46b, respectively, into a displacement motion of the lens 18. The first and the second junction 58a, 58b are thereby spaced apart from one another in a direction at right angles to the displacement direction of the lens 18.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: September 20, 2011
    Assignee: Raylase AG
    Inventor: Erwin Wagner
  • Patent number: 7807864
    Abstract: Disclosed is a transgenic non-human animal with broad or cell type-specific ectopic expression of fra-2 that manifests itself in a fibrotic disease, methods for obtaining such animal and their use. Fra-2 transgenic animals, in particular mice, are useful as model systems for human fibrotic disease, e.g. lung scleroderma and pulmonary fibrosis. Cells obtained from the animal are useful for the analysis of fibrotic disease and for testing compounds useful in the therapy of fibrotic disease.
    Type: Grant
    Filed: February 21, 2006
    Date of Patent: October 5, 2010
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Erwin Wagner, Robert Eferl
  • Publication number: 20100003385
    Abstract: A process of precooking grains which comprises the steps of: a) Charging the grains into a reactor in a controlled manner; b) Applying a first negative pressure to the reactor; c) Heating the grains contained in the reactor; d) Applying a second negative pressure to the reactor; and e) Cooling the grains. Equipment for precooking grains comprises at least one reactor, which is associable with means for applying negative pressure.
    Type: Application
    Filed: July 6, 2009
    Publication date: January 7, 2010
    Inventor: Werner Erwin Wagner
  • Publication number: 20090242437
    Abstract: A package for an optical storage medium, comprising: a cover part; a support part having a first part, a second part and a support region, wherein, when an optical storage medium is inserted in the package, the support region abuts at least partly against the optical storage medium; an overlay, wherein the overlay and the second part form a receptacle; a hinge located between the first and second parts, wherein the hinge at least partially runs through the support region; wherein the package is made out of a single piece of paper or cardboard.
    Type: Application
    Filed: February 26, 2009
    Publication date: October 1, 2009
    Applicant: SONY DADC Austria AG
    Inventors: Dieter DAUM, Guenther Schindlauer, Erwin Wagner, Katherin Feldmaier, Anton Rangetiner
  • Publication number: 20090122377
    Abstract: Shown is a lens device 16 comprising a displaceable lens 18 and a guide 42, by means of which the lens is guided so as to be capable of being displaced. The lens device 16 comprises a first and a second galvanometric motor 46a, 46b and a first and a second force transmission device 54a, 56a; 54b, 56b, which is coupled to the rotor of the first and second galvanometric motor 46a, 46b, respectively, and which is coupled to the lens 18 at a first and second junction 58a, 58b, respectively. The force transmission device is suitable to convert a rotary motion of the rotor of the first and second galvanometric motor 46a, 46b, respectively, into a displacement motion of the lens 18. The first and the second junction 58a, 58b are thereby spaced apart from one another in a direction at right angles to the displacement direction of the lens 18.
    Type: Application
    Filed: October 31, 2008
    Publication date: May 14, 2009
    Applicant: RAYLASE AG
    Inventor: Erwin WAGNER
  • Publication number: 20080123704
    Abstract: Disclosed is a system (10) for regulating the power of a laser beam (12).
    Type: Application
    Filed: November 19, 2007
    Publication date: May 29, 2008
    Applicant: Raylase AG
    Inventors: Peter Von Jan, Erwin Wagner, Alistair Baillie Gill
  • Patent number: 7247767
    Abstract: A mouse that is deficient for c-Jun and JunB in the epidermis or in which deletion of c-Jun and JunB can be specifically induced in the epidermis, and methods for obtaining such mice. The mice and keratinocytes derived therefrom are useful as an animal model for psoriasis and psoriatic arthritis.
    Type: Grant
    Filed: January 21, 2005
    Date of Patent: July 24, 2007
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Rainer Zenz, Erwin Wagner
  • Publication number: 20060195916
    Abstract: Disclosed is a transgenic non-human animal with broad or cell type-specific ectopic expression of fra-2 that manifests itself in a fibrotic disease, methods for obtaining such animal and their use. Fra-2 transgenic animals, in particular mice, are useful as model systems for human fibrotic disease, e.g. lung scleroderma and pulmonary fibrosis. Cells obtained from the animal are useful for the analysis of fibrotic disease and for testing compounds useful in the therapy of fibrotic disease.
    Type: Application
    Filed: February 21, 2006
    Publication date: August 31, 2006
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Erwin Wagner, Robert Eferl
  • Publication number: 20050268348
    Abstract: A mouse that is deficient for c-Jun and JunB in the epidermis or in which deletion of c-Jun and JunB can be specifically induced in the epidermis, and methods for obtaining such mice. The mice and keratinocytes derived therefrom are useful as an animal model for psoriasis and psoriatic arthritis.
    Type: Application
    Filed: January 21, 2005
    Publication date: December 1, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Rainer Zenz, Erwin Wagner
  • Patent number: 6834062
    Abstract: The present invention provides a method and apparatus for controlling laser power, using at least two Brewster windows which are aligned along an axis which is parallel to the direction of the laser beam and which are rotatable around said axis, wherein the first Brewster window is rotated in one direction and the second Brewster window is rotated in the opposite direction. Preferably, both Brewster windows only have to rotate each through +/−45° to control transmission of the laser beam from maximum to minimum.
    Type: Grant
    Filed: July 22, 2002
    Date of Patent: December 21, 2004
    Assignee: Raylase AG
    Inventors: Stephen Hastings, Peter Dullin, Alistair Gill, Erwin Wagner, Peter von Jan, Wolfgang Hauck
  • Publication number: 20030229912
    Abstract: A non-human mammal that carries germline mutations in both the p53 and the Fos genes, methods for producing it and cell lines derived therefrom. The p53/Fos double knockout animal, in particular a mouse, is useful as a rhabdomyosarcoma disease model.
    Type: Application
    Filed: March 28, 2003
    Publication date: December 11, 2003
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Alexander Fleischmann, Erwin Wagner, Wolfram Jochum, Martin Radolf
  • Publication number: 20030086451
    Abstract: The present invention provides a method and apparatus for controlling laser power, using at least two Brewster windows which are aligned along an axis which is parallel to the direction of the laser beam and which are rotatable around said axis, wherein the first Brewster window is rotated in one direction and the second Brewster window is rotated in the opposite direction. Preferably, both Brewster windows only have to rotate each through +/−45° to control transmission of the laser beam from maximum to minimum.
    Type: Application
    Filed: July 22, 2002
    Publication date: May 8, 2003
    Inventors: Stephen Hastings, Peter Dullin, Alistair Gill, Erwin Wagner, Peter Von Jan, Wolfgang Hauck
  • Patent number: 6492575
    Abstract: Process for producing mammals with defined genetic properties, particularly transgenic mammals. Animals which are derived completely from ES cells are obtained by injecting totipotent cells (embryonic stem cells or embryonic germ cells) genetically manipulated and cultured in vitro into tetraploid blastocysts and implanting the resulting embryo in a foster mother, in a single operation.
    Type: Grant
    Filed: December 28, 1999
    Date of Patent: December 10, 2002
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Erwin Wagner, Zhao-Qi Wang
  • Publication number: 20020178457
    Abstract: Process for producing mammals with defined genetic properties, particularly transgenic mammals. Animals which are derived completely from ES cells are obtained by injecting totipotent cells (embryonic stem cells or embryonic germ cells) genetically manipulated and cultured in vitro into tetraploid blastocysts and implanting the resulting embryo in a foster mother, in a single operation.
    Type: Application
    Filed: December 28, 1999
    Publication date: November 28, 2002
    Inventors: ERWIN WAGNER, ZHAO-QI WANG
  • Patent number: 5389541
    Abstract: The invention includes a mouse erythroblastoid cell line whose growth is responsive to levels of erythropoietin present in the cell line's growth medium. Also disclosed are methods of using the mouse erythroblastoid cell line to assay the amount of erythropoietin that is present in a sample.
    Type: Grant
    Filed: February 18, 1993
    Date of Patent: February 14, 1995
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Gordon Keller, Harmut Beug, Erwin Wagner
  • Patent number: D609563
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: February 9, 2010
    Assignee: Sony DADC Austria AG
    Inventors: Dieter Daum, Günther Schindlauer, Erwin Wagner, Kathrin Feldmaier, Anton Rangetiner